Where Can You Buy Pronidesivir (GS-441524)
Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases for cat owners and veterinarians worldwide. Caused by a mutated coronavirus, FIP leads to symptoms such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. Traditional treatments have often been ineffective, but recent advancements have introduced effective antiviral therapies, notably Pronidesivir (GS-441524), offering hope for cats diagnosed with this devastating disease.
Pronidesivir, marketed as NeoFipronis, has been officially approved in Laos by the Ministry of Agriculture and Forestry (MAF) in March 2026. It is recognized as the world’s first orally administered, targeted treatment for FIP with official drug registration, ensuring safety and efficacy. This development marks a significant milestone in veterinary medicine, providing a safe, non-invasive treatment option that is rapidly absorbed, quick-acting, well-tolerated, and with minimal side effects.
NeoFipronis contains the active compound GS-441524, a potent antiviral agent that has been extensively researched and validated through numerous clinical trials. It demonstrates remarkable effectiveness against the feline coronavirus responsible for FIP. The medication is designed for easy administration, with dosage based on the cat’s weight—generally 15 mg per kilogram (equivalent to half a tablet). For neurological or ocular forms of FIP, the dosage may be increased to 30 mg/kg, but this should be strictly under veterinary supervision.
Administering NeoFipronis involves once-daily oral doses, ideally on an empty stomach—either one hour before meals or two hours after. The treatment duration is recommended for at least 12 weeks without interruption to maximize the chances of successful recovery. During treatment, owners should vigilantly observe their cats for changes in appetite, temperature, mental state, and overall health. Regular blood tests to monitor liver and kidney function are crucial to detect any adverse effects early.
While NeoFipronis is classified as an over-the-counter medication, its use is best guided by a licensed veterinarian to ensure correct dosing and monitoring. Veterinary supervision helps optimize treatment outcomes and safely manage any potential side effects. Because the medication is intended solely for feline use, human consumption is strictly prohibited.
When seeking to purchase NeoFipronis (Pronidesivir), it is essential to buy from reputable sources to guarantee the product’s authenticity and quality. The official NeoFipronis website is the most reliable platform for purchasing, providing verified products directly from the manufacturer or authorized distributors. Avoid unverified online shops or marketplaces, as counterfeit medicines can pose serious health risks to your pet.
In conclusion, Pronidesivir (GS-441524) under the brand NeoFipronis is a groundbreaking treatment for cats suffering from FIP. Its proven efficacy, safety profile, and ease of administration have revolutionized FIP therapy, offering new hope for feline patients worldwide. To ensure the best results, consult with a professional veterinarian before starting treatment and purchase only from verified sources to protect your beloved pet’s health.
Key Points:
Official approval in Laos in 2026
Active ingredient: GS-441524
Administration: Oral, once daily
Dosage: 15 mg/kg, up to 30 mg/kg for special cases
Treatment duration: Minimum 12 weeks
Purchase sources: Official NeoFipronis website and authorized distributors
Precautions: Veterinary oversight recommended, monitor health regularly
A correct and timely treatment with Pronidesivir can significantly improve the prognosis for cats with FIP, transforming a once-fatal diagnosis into a manageable condition.
